Recent court rulings have thrust the 340B Drug Pricing Program back in the headlines, and it is worth examining some of the lesser-known aspects of how this program interacts with state and federal Medicaid dollars, specifically through the Medicaid Drug Rebate Program (MDRP). While well-intentioned and created with bipartisan support, both initiatives have now morphed, […]
